Literature DB >> 11277952

Which intercurrent infections are associated with maculopapular cutaneous drug reactions? A case-control study.

A D Cohen1, M Friger, B Sarov, S Halevy.   

Abstract

BACKGROUND: Patients with lymphotrophic viral infections are at increased risk for cutaneous drug reactions (CDRs). However, the association between other intercurrent infections and maculopapular CDRs has not been evaluated by epidemiologic methods.
OBJECTIVE: We conducted a case-control study in order to evaluate the exposure to intercurrent infections in patients with maculopapular CDRs.
METHODS: Data were obtained through assessment of files of 53 patients hospitalized for maculopapular CDRs in the Department of Dermatology and 159 control patients. Exposure to intercurrent infections was recorded in patients and controls.
RESULTS: An intercurrent infectious disease was documented in 31/53 (58.5%) of patients with CDRs, as compared to 12/159 (7.5%) patients in the control group (OR 17.26, 95% CI: 7.24-42.00). Maculopapular CDRs were associated with respiratory tract infections (OR 20.53, 95% CI: 5.20-94.45), and urinary tract infections (OR 20.61, 95% CI: 2.36-465.99), but not with skin infections (OR 3.83, 95% CI: 0.85-17.87) or other infections.
CONCLUSIONS: Our study implies that maculopapular CDRs are associated with respiratory tract infections as well as urinary tract infections. Further study is needed to evaluate the role of intercurrent infections in the pathogenesis of CDRs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11277952     DOI: 10.1046/j.1365-4362.2001.00081.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  2 in total

Review 1.  Antibiotic Allergy in Pediatrics.

Authors:  Allison Eaddy Norton; Katherine Konvinse; Elizabeth J Phillips; Ana Dioun Broyles
Journal:  Pediatrics       Date:  2018-05       Impact factor: 7.124

2.  The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge.

Authors:  Jean-Christoph Caubet; Laurent Kaiser; Barbara Lemaître; Benoît Fellay; Alain Gervaix; Philippe A Eigenmann
Journal:  J Allergy Clin Immunol       Date:  2010-10-28       Impact factor: 10.793

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.